ReviewOncogene2024

Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019-2023.

Stephen K Burley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.